Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 3481 AL 3495

Erythrocytes as markers of oxidative stress related pathologies

Massaccesi L, Galliera E, Corsi Romanelli MM.

Mech Ageing Dev. 2020 Oct;191:111333. doi: 10.1016/j.mad.2020.111333. Epub 2020 Aug 16.

Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease

Carapelle E, Mundi C, Cassano T, Avolio C.

Int J Mol Sci. 2020 Aug 30;21(17):6279. doi: 10.3390/ijms21176279.

[Epidemiology of Alzheimer's disease: latest trends]

Dumurgier J, Sabia S.

Rev Prat. 2020 Feb;70(2):149-151.

[Alzheimer's disease: a biological disorder?]

Hugon J.

Rev Prat. 2020 Feb;70(2):152-155.

A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group

O'Gorman C, Khoury R, Anderson A, Carter M, DiCesare F, Dubé S, Ereshefsky L, Grossberg G, Hefting N, Khan S, Lind S, Moebius H, Shiovitz T, Rosenberg P.

J Prev Alzheimers Dis. 2020;7(4):274-282. doi: 10.14283/jpad.2020.37.

Cortisol hypersecretion and the risk of Alzheimer's disease: A systematic review and meta-analysis

Zheng B, Tal R, Yang Z, Middleton L, Udeh-Momoh C.

Ageing Res Rev. 2020 Dec;64:101171. doi: 10.1016/j.arr.2020.101171. Epub 2020 Sep 22.

Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline

Pettigrew C, Soldan A, Wang J, Wang MC, Arthur K, Moghekar A, Gottesman RF, Albert M.

Neurology. 2020 Dec 8;95(23):e3093-e3103. doi: 10.1212/WNL.0000000000010946. Epub 2020 Sep 28.

Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation

Liu Y, Li H, Wang J, Xue Q, Yang X, Kang Y, Li M, Xu J, Li G, Li C, Chang HC, Su KP, Wang F.

JAMA Netw Open. 2020 Oct 1;3(10):e2018777. doi: 10.1001/jamanetworkopen.2020.18777.

Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis

Czakó C, Kovács T, Ungvari Z, Csiszar A, Yabluchanskiy A, Conley S, Csipo T, Lipecz A, Horváth H, Sándor GL, István L, Logan T, Nagy ZZ, Kovács I.

Geroscience. 2020 Dec;42(6):1499-1525. doi: 10.1007/s11357-020-00252-7. Epub 2020 Oct 4.

Sleep-disordered breathing and the risk of Alzheimer's disease

Liguori C, Maestri M, Spanetta M, Placidi F, Bonanni E, Mercuri NB, Guarnieri B.

Sleep Med Rev. 2021 Feb;55:101375. doi: 10.1016/j.smrv.2020.101375. Epub 2020 Sep 6.

Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration

Busatto Filho G, Duran FLS, Squarzoni P, Coutinho AMN, Rosa PGP, Torralbo L, Pachi CGDF, da Costa NA, Porto FHG, Carvalho CL, Brucki SMD, Nitrini R, Forlenza OV, Leite CDC, Buchpiguel CA, de Paula Faria D.

J Neurosci Res. 2021 Feb;99(2):481-501. doi: 10.1002/jnr.24739. Epub 2020 Oct 18.

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suárez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Rial AM, Pascoal TA, Andreasson U, Schöll M, Weiner MW, Rosa-Neto P, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H; Alzheimer’s Disease Neuroimaging Initiative.

Mol Psychiatry. 2021 Feb;26(2):429-442. doi: 10.1038/s41380-020-00923-z. Epub 2020 Oct 26.

Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer's Disease: A Systematic Review and Meta-Analysis

Dulewicz M, Kulczyńska-Przybik A, Mroczko B.

Int J Mol Sci. 2020 Nov 6;21(21):8335. doi: 10.3390/ijms21218335.

Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer's disease created by integrative analysis of multi-omics data

Shigemizu D, Akiyama S, Higaki S, Sugimoto T, Sakurai T, Boroevich KA, Sharma A, Tsunoda T, Ochiya T, Niida S, Ozaki K.

Alzheimers Res Ther. 2020 Nov 10;12(1):145. doi: 10.1186/s13195-020-00716-0.

[Analysis of cerebrospinal fluid in the diagnosis of cognitive impairment and dementia]

Frederiksen KS, Hasselbalch S, Waldemar G.

Ugeskr Laeger. 2020 Nov 2;182(45):V05200352.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias